Invention Grant
US08163745B2 HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
有权
HIV抑制5-（羟基亚甲基和氨基亚甲基）取代的嘧啶
- Patent Title: HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
- Patent Title (中): HIV抑制5-（羟基亚甲基和氨基亚甲基）取代的嘧啶
-
Application No.: US12294725Application Date: 2007-03-30
-
Publication No.: US08163745B2Publication Date: 2012-04-24
- Inventor: Jerôme Emile Georges Guillemont , Céline Isabelle Mordant , Benoit Antoine Schmitt
- Applicant: Jerôme Emile Georges Guillemont , Céline Isabelle Mordant , Benoit Antoine Schmitt
- Applicant Address: IE Little Island
- Assignee: Tibotec Pharmaceuticals Ltd.
- Current Assignee: Tibotec Pharmaceuticals Ltd.
- Current Assignee Address: IE Little Island
- Priority: EP06112045 20060330
- International Application: PCT/EP2007/053113 WO 20070330
- International Announcement: WO2007/113256 WO 20071011
- Main IPC: C07D239/46
- IPC: C07D239/46 ; C07D417/06 ; A61K31/506
Abstract:
This invention concerns 5-(hydroxymethylene and aminomethylene)pyrimidine derivatives having HIV (Human Immunodeficiency Virus) replication inhibiting properties, to the preparation thereof and to pharmaceutical compositions comprising these compounds.
Public/Granted literature
- US20100234375A1 HIV INHIBITING 5-(HYDROXYMETHYLENE AND AMINOMETHYLENE) SUBSTITUTED PYRIMIDINES Public/Granted day:2010-09-16
Information query
